Atlas Trials

Pilot Study of DRibble Vaccine for Prostate Cancer Patients

Clinical trial NCT02234921 · COMPLETED

Trial details

NCT number
NCT02234921
Sponsor
UbiVac
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Adenocarcinoma of the Prostate
Start date
2014-10-24
Primary completion
2018-08-15
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.